Ciaran M. Lee

6.3k total citations · 2 hit papers
59 papers, 4.2k citations indexed

About

Ciaran M. Lee is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ciaran M. Lee has authored 59 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 21 papers in Genetics and 7 papers in Oncology. Recurrent topics in Ciaran M. Lee's work include CRISPR and Genetic Engineering (44 papers), Virus-based gene therapy research (16 papers) and RNA and protein synthesis mechanisms (13 papers). Ciaran M. Lee is often cited by papers focused on CRISPR and Genetic Engineering (44 papers), Virus-based gene therapy research (16 papers) and RNA and protein synthesis mechanisms (13 papers). Ciaran M. Lee collaborates with scholars based in United States, Ireland and Denmark. Ciaran M. Lee's co-authors include Gang Bao, Thomas J. Cradick, Kam W. Leong, Timothy Davis, Eli J. Fine, Matthew H. Porteus, Hae‐Won Kim, Syandan Chakraborty, Mingqiang Li and Hongxia Wang and has published in prestigious journals such as Chemical Reviews, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Ciaran M. Lee

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

2018 541 citations Christopher A. Vakulskas, Daniel P. Dever et al. Nature Medicine profile →
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery

2017 460 citations Hongxia Wang, Mingqiang Li et al. Chemical Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ciaran M. Lee United States	30	3.5k	1.2k	702	342	316	59	4.2k
Holly A. Rees United States	17	7.1k 2.0×	1.9k 1.6×	379 0.5×	679 2.0×	139 0.4×	18	7.5k
Richard Surosky United States	20	2.2k 0.6×	1.1k 0.9×	369 0.5×	121 0.4×	154 0.5×	33	2.8k
Nicola Crosetto Sweden	30	3.7k 1.1×	428 0.3×	1.0k 1.5×	88 0.3×	294 0.9×	72	4.6k
James P. Carney United States	20	4.3k 1.2×	753 0.6×	1.3k 1.8×	113 0.3×	133 0.4×	30	4.8k
David I. Bryson United States	8	3.1k 0.9×	808 0.6×	165 0.2×	257 0.8×	51 0.2×	10	3.2k
Xiaogang Wang China	25	2.1k 0.6×	336 0.3×	221 0.3×	91 0.3×	134 0.4×	53	2.7k
Yongsub Kim South Korea	18	1.8k 0.5×	441 0.4×	100 0.1×	237 0.7×	74 0.2×	43	2.1k
Roger P. Hollis United States	27	1.7k 0.5×	1.1k 0.9×	425 0.6×	55 0.2×	249 0.8×	58	2.2k
Francisco Martı́n Spain	30	1.7k 0.5×	713 0.6×	554 0.8×	21 0.1×	551 1.7×	119	3.0k
Samagya Banskota United States	16	1.7k 0.5×	567 0.5×	146 0.2×	84 0.2×	125 0.4×	20	2.1k

Countries citing papers authored by Ciaran M. Lee

Since Specialization

Citations

This map shows the geographic impact of Ciaran M. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciaran M. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciaran M. Lee more than expected).

Fields of papers citing papers by Ciaran M. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciaran M. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciaran M. Lee. The network helps show where Ciaran M. Lee may publish in the future.

Co-authorship network of co-authors of Ciaran M. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ciaran M. Lee. A scholar is included among the top collaborators of Ciaran M. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciaran M. Lee. Ciaran M. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Ciaran M., et al.. (2025). A CRISPRi Gene Regulation System for Bifidobacteria. Microbial Biotechnology. 18(11). e70260–e70260. 1 indexed citations

Alessandri, Giulia, Ciaran M. Lee, Federico Fontana, et al.. (2024). GH136 ‐encoding gene ( per B ) is involved in gut colonization and persistence by Bifidobacterium bifidum PRL2010. Microbial Biotechnology. 17(2). e14406–e14406. 9 indexed citations

Pille, Melissa, So Hyun Park, Haipeng Xue, et al.. (2024). Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Molecular Therapy — Methods & Clinical Development. 32(1). 101208–101208. 6 indexed citations

Fernando, Lawrence P., et al.. (2022). Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes. The CRISPR Journal. 5(3). 397–409. 10 indexed citations

Allen, Daniel, Lucien E. Weiss, Michael A. Rosenberg, et al.. (2022). High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells. The CRISPR Journal. 5(1). 80–94. 16 indexed citations

Woznicki, Jerzy A., Peter F. Flood, Ciaran M. Lee, et al.. (2021). TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells. Cell Death and Disease. 12(10). 864–864. 109 indexed citations

Schneller, Jessica L., Ciaran M. Lee, Randy J. Chandler, et al.. (2021). In vivo genome editing at the albumin locus to treat methylmalonic acidemia. Molecular Therapy — Methods & Clinical Development. 23. 619–632. 13 indexed citations

Sharma, Rajiv P., Daniel P. Dever, Ciaran M. Lee, et al.. (2021). The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells. Nature Communications. 12(1). 472–472. 21 indexed citations

Thadani, Nicole N., et al.. (2020). Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers. ACS Synthetic Biology. 9(3). 461–467. 9 indexed citations

10.

Bao, Xiaoping, et al.. (2020). Tools for experimental and computational analyses of off-target editing by programmable nucleases. Nature Protocols. 16(1). 10–26. 64 indexed citations

11.

Tong, Sheng, Buhle Moyo, Ciaran M. Lee, Kam W. Leong, & Gang Bao. (2019). Engineered materials for in vivo delivery of genome-editing machinery. Nature Reviews Materials. 4(11). 726–737. 174 indexed citations

12.

Humbert, Olivier, Stefan Radtke, Sowmya Reddy, et al.. (2019). Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates. Science Translational Medicine. 11(503). 87 indexed citations

13.

Gomez‐Ospina, Natalia, Rasmus O. Bak, Sruthi Mantri, et al.. (2019). Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Nature Communications. 10(1). 4045–4045. 93 indexed citations

14.

Zhu, Haibao, Linlin Zhang, Sheng Tong, et al.. (2018). Spatial control of in vivo CRISPR–Cas9 genome editing via nanomagnets. Nature Biomedical Engineering. 3(2). 126–136. 123 indexed citations

15.

Vakulskas, Christopher A., Daniel P. Dever, Garrett R. Rettig, et al.. (2018). A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine. 24(8). 1216–1224. 541 indexed citations breakdown →

16.

Wang, Hongxia, Mingqiang Li, Ciaran M. Lee, et al.. (2017). CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery. Chemical Reviews. 117(15). 9874–9906. 460 indexed citations breakdown →

17.

Dever, Daniel P., Joab Camarena, Ciaran M. Lee, et al.. (2017). Preclinical Development of HBB Gene Correction in Autologous Hematopoietic Stem and Progenitor Cells to Treat Severe Sickle Cell Disease. Blood. 130. 4620–4620. 4 indexed citations

18.

Lee, Ciaran M., et al.. (2016). Treating hemoglobinopathies using gene-correction approaches: promises and challenges. Human Genetics. 135(9). 993–1010. 9 indexed citations

19.

Zhao, Jing, Dalia Arafat, Thomas J. Cradick, et al.. (2016). A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood. The American Journal of Human Genetics. 98(2). 299–309. 50 indexed citations

20.

Lee, Ciaran M., et al.. (2015). Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection. Scientific Reports. 5(1). 16031–16031. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact